Highbridge Capital Management’s Bio-Techne TECH Stock Holding History

Highbridge Capital Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-20,376	Closed	-$458K	–	1803
2015 Q4	$458K	Buy	+20,376	New	+$465K	0.01%	1029
2015 Q3	–	Sell	-9,956	Closed	-$245K	–	1805
2015 Q2	$245K	Buy	+9,956	New	+$249K	﹤0.01%	1214
2015 Q1	–	Sell	-149,912	Closed	-$3.46M	–	1583
2014 Q4	$3.46M	Buy	+149,912	New	+$3.43M	0.04%	365
2013 Q4	–	Sell	-437,128	Closed	-$8.75M	–	1316
2013 Q3	$8.75M	Buy	437,128 +36,932	+9%	+$701K	0.09%	251
2013 Q2	$6.91M	Buy	+400,196	New	+$6.64M	0.07%	274

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Highbridge Capital Management's TECH Position: Q1 2016 in Review

Highbridge Capital Management sold out of Bio-Techne (TECH) in Q1 2016, closing a stake of 20,376 shares — an estimated $458K sold.

Highbridge Capital Management first reported a position in TECH in Q2 2013 and held it in 5 quarters. The position peaked at $8.75M in Q3 2013. 257 funds tracked by Wall St. Rank hold TECH as of Q1 2016.

Highbridge Capital Management reported no remaining Bio-Techne position as of Q1 2016 after selling out during the quarter.
Highbridge Capital Management sold 20,376 Bio-Techne shares in Q1 2016, an estimated $458K.
Highbridge Capital Management first reported a position in Bio-Techne in Q2 2013 and held it in 5 quarters.
Highbridge Capital Management's Bio-Techne position peaked at $8.75M in Q3 2013.
257 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2016.

Based on Highbridge Capital Management's 13F filing for Q1 2016, filed 16 May 2016.